Certara, Inc. (CERT)
NASDAQ • Healthcare
Last close at October 23, 2026 at 20:00 UTC
Metrics Over Time
Where the Money Goes
Q2 2026In plain terms: out of every $100 in revenue, Certara, Inc. currently loses $59.
Fundamentals & Financials
TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.
Income Statement
Balance Sheet
Financial Highlights
Dividends History
Split History
Earnings
Nov 5
in 11 daysQ4 2026% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS
Certara trailed consensus on both the top and bottom line as revenue fell 10.8% year over year to about $93.3 million in the second fiscal quarter of 2026, reported August 4, 2026, based on preliminary results. Revenue of $93.3 million trailed the $98.1 million estimate (-4.9%), down from about $104.6 million a year ago, while adjusted EPS of $0.08 trailed the $0.09 estimate (-10%) but rose 14.3% from $0.07 a year earlier. Profitability held with gross profit of roughly $58.1 million and gross margin at about 62.3%. The quarter generated operating cash flow of about $10.0 million, and the company repurchased roughly $17.4 million of stock. For the next period, consensus calls for EPS of $0.09 on revenue of $91.9 million.
Next report — what to expect
Certara, Inc. (CERT) reports earnings on November 5, 2026, with consensus calling for EPS of $0.09 on revenue of $92.6 million. As trailing context, revenue fell -10.8% year over year last quarter. The company has beaten EPS in 4 of its 8 most recent quarters.
About Certara, Inc.
Certara, Inc. (NASDAQ: CERT) provides drug-development software and technology-enabled services for healthcare organizations, centered on biosimulation across the development lifecycle. The company operates in medical and healthcare information services and generated $418.8 million of revenue in FY2025, serving biopharmaceutical, academic, and government customers through software and services tied to research, regulatory work, and market access.
Today's Snapshot
The day ended with CERT 2.4% higher at 10.33, outperforming a weaker sector. CERT is due to report earnings on 5 November.
Trading Volume
Below 10d avg (2.0M)
1.4M
vs S&P 500 Today
Outperforming Market
+2.90%
Updated: October 23, 2026 at 20:11 UTC
Technical Indicators
All signalsHide signals
- EMA (5 indicators)$8.00 - $9.78Buy
- RSI (14)65.29Neutral
- Stochastic %K (14, 3, 3)92.87Sell
- MACD Level (12, 26)0.39Buy
Peers & Related Assets
Get premium market insights delivered directly to your inbox.